Literature DB >> 20065296

Haploinsufficiency of Apc leads to ineffective hematopoiesis.

Jianghong Wang1, Anthony A Fernald, John Anastasi, Michelle M Le Beau, Zhijian Qian.   

Abstract

Loss of a whole chromosome 5 or a deletion of the long arm of chromosome 5, -5/del(5q), is a recurring abnormality in myeloid neoplasms. The APC gene is located at chromosome band 5q23, and is deleted in more than 95% of patients with a -5/del(5q), raising the question of whether haploinsufficiency of APC contributes to the development of myeloid neoplasms with loss of 5q. We show that conditional inactivation of a single allele of Apc in mice leads to the development of severe anemia with macrocytosis and monocytosis. Further characterization of the erythroid lineage revealed that erythropoiesis is blocked at the early stages of differentiation. The long-term hematopoietic stem cell (LT-HSC) and short-term HSC (ST-HSC) populations are expanded in Apc-heterozygous mice compared with the control littermates; however, the HSCs have a reduced capacity to regenerate hematopoiesis in vivo in the absence of a single allele of Apc. Apc heterozygous myeloid progenitor cells display an increased frequency of apoptosis, and decreased in vitro colony-forming capacity, recapitulating several characteristic features of myeloid neoplasms with a -5/del(5q). Our results indicate that haploinsufficiency of Apc impairs hematopoiesis, and raise the possibility that loss of function of APC contributes to the development of myelodysplasia.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20065296      PMCID: PMC3372947          DOI: 10.1182/blood-2009-11-251835

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  PTEN maintains haematopoietic stem cells and acts in lineage choice and leukaemia prevention.

Authors:  Jiwang Zhang; Justin C Grindley; Tong Yin; Sachintha Jayasinghe; Xi C He; Jason T Ross; Jeffrey S Haug; Dawn Rupp; Kimberly S Porter-Westpfahl; Leanne M Wiedemann; Hong Wu; Linheng Li
Journal:  Nature       Date:  2006-04-23       Impact factor: 49.962

2.  Roles of eukaryotic ribosomal proteins in maturation and transport of pre-18S rRNA and ribosome function.

Authors:  Sébastien Ferreira-Cerca; Gisela Pöll; Pierre-Emmanuel Gleizes; Herbert Tschochner; Philipp Milkereit
Journal:  Mol Cell       Date:  2005-10-28       Impact factor: 17.970

3.  Multilineage transcriptional priming and determination of alternate hematopoietic cell fates.

Authors:  Peter Laslo; Chauncey J Spooner; Aryeh Warmflash; David W Lancki; Hyun-Jun Lee; Roger Sciammas; Benjamin N Gantner; Aaron R Dinner; Harinder Singh
Journal:  Cell       Date:  2006-08-25       Impact factor: 41.582

Review 4.  Wnt signalling and the actin cytoskeleton.

Authors:  T Akiyama; Y Kawasaki
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

5.  Activation of the canonical Wnt pathway leads to loss of hematopoietic stem cell repopulation and multilineage differentiation block.

Authors:  Peggy Kirstetter; Kristina Anderson; Bo T Porse; Sten Eirik W Jacobsen; Claus Nerlov
Journal:  Nat Immunol       Date:  2006-09-03       Impact factor: 25.606

6.  Hematopoietic stem cell and multilineage defects generated by constitutive beta-catenin activation.

Authors:  Marina Scheller; Joerg Huelsken; Frank Rosenbauer; Makoto M Taketo; Walter Birchmeier; Daniel G Tenen; Achim Leutz
Journal:  Nat Immunol       Date:  2006-09-03       Impact factor: 25.606

7.  TSC2 integrates Wnt and energy signals via a coordinated phosphorylation by AMPK and GSK3 to regulate cell growth.

Authors:  Ken Inoki; Hongjiao Ouyang; Tianqing Zhu; Charlotta Lindvall; Yian Wang; Xiaojie Zhang; Qian Yang; Christina Bennett; Yuko Harada; Kryn Stankunas; Cun-Yu Wang; Xi He; Ormond A MacDougald; Ming You; Bart O Williams; Kun-Liang Guan
Journal:  Cell       Date:  2006-09-08       Impact factor: 41.582

8.  Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.

Authors:  Andrea Pellagatti; Mario Cazzola; Aristoteles A N Giagounidis; Luca Malcovati; Matteo G Della Porta; Sally Killick; Lisa J Campbell; Li Wang; Cordelia F Langford; Carrie Fidler; David Oscier; Carlo Aul; James S Wainscoat; Jacqueline Boultwood
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

9.  Age and manifestation related symptoms in familial adenomatous polyposis.

Authors:  Roland S Croner; Wolfgang M Brueckl; Bertram Reingruber; Werner Hohenberger; Klaus Guenther
Journal:  BMC Cancer       Date:  2005-03-02       Impact factor: 4.430

10.  A critical role for Apc in hematopoietic stem and progenitor cell survival.

Authors:  Zhijian Qian; Lina Chen; Anthony A Fernald; Bart O Williams; Michelle M Le Beau
Journal:  J Exp Med       Date:  2008-08-25       Impact factor: 14.307

View more
  36 in total

Review 1.  Molecular dissection of the 5q deletion in myelodysplastic syndrome.

Authors:  Benjamin L Ebert
Journal:  Semin Oncol       Date:  2011-10       Impact factor: 4.929

2.  Clonal evolution in myelodysplastic syndromes with isolated del(5q): the importance of genetic monitoring.

Authors:  Martin Jädersten; Aly Karsan
Journal:  Haematologica       Date:  2011-02       Impact factor: 9.941

3.  Wnt Signaling in Normal and Malignant Stem Cells.

Authors:  Dheeraj Bhavanasi; Peter S Klein
Journal:  Curr Stem Cell Rep       Date:  2016-10-13

4.  Global transcriptome analyses of human and murine terminal erythroid differentiation.

Authors:  Xiuli An; Vincent P Schulz; Jie Li; Kunlu Wu; Jing Liu; Fumin Xue; Jingping Hu; Narla Mohandas; Patrick G Gallagher
Journal:  Blood       Date:  2014-03-17       Impact factor: 22.113

5.  Inhibition of WNT signaling in the bone marrow niche prevents the development of MDS in the Apcdel/+ MDS mouse model.

Authors:  Angela Stoddart; Jianghong Wang; Chunmei Hu; Anthony A Fernald; Elizabeth M Davis; Jason X Cheng; Michelle M Le Beau
Journal:  Blood       Date:  2017-03-27       Impact factor: 22.113

6.  Allelic methylation levels of the noncoding VTRNA2-1 located on chromosome 5q31.1 predict outcome in AML.

Authors:  Marianne Bach Treppendahl; Xiangning Qiu; Alexandra Søgaard; Xiaojing Yang; Cecilie Nandrup-Bus; Christoffer Hother; Mette Klarskov Andersen; Lars Kjeldsen; Lars Möllgård; Lars Möllgaard; Eva Hellström-Lindberg; Johan Jendholm; Bo T Porse; Peter A Jones; Gangning Liang; Kirsten Grønbæk
Journal:  Blood       Date:  2011-11-04       Impact factor: 22.113

Review 7.  Therapy-related myeloid neoplasms: when genetics and environment collide.

Authors:  Megan E McNerney; Lucy A Godley; Michelle M Le Beau
Journal:  Nat Rev Cancer       Date:  2017-08-24       Impact factor: 60.716

8.  Knockdown of Hspa9, a del(5q31.2) gene, results in a decrease in hematopoietic progenitors in mice.

Authors:  Tim H-P Chen; Amal Kambal; Kilannin Krysiak; Mark A Walshauser; Gagan Raju; Justin F Tibbitts; Matthew J Walter
Journal:  Blood       Date:  2010-12-01       Impact factor: 22.113

Review 9.  Myelodysplastic syndromes.

Authors:  Olatoyosi Odenike; John Anastasi; Michelle M Le Beau
Journal:  Clin Lab Med       Date:  2011-10-10       Impact factor: 1.935

Review 10.  Engineering mouse models with myelodysplastic syndrome human candidate genes; how relevant are they?

Authors:  Stephanie Beurlet; Christine Chomienne; Rose Ann Padua
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.